廣東開展第二輪走訪上市公司工作 涉保利發展及白雲山等
內媒報道,廣東證監局、廣東省委金融辦、廣東省住建廳、廣州市地方金融監管局、廣州市住建局等部門於昨日(6日)聯合走訪保利發展(600048.SH)、白雲山(600332.SH)和僑銀股份(002973.SZ)等上市公司,開展實地調研,協調解決企業在生產經營中遇到的實際困難和問題,進一步加大對上市公司等優秀企業的支持力度。
日前,「部署走訪上市公司工作,推動上市公司高質量發展」全國視頻會議在京召開。廣東省在春節前走訪調研溫氏股份(300498.SZ)、融捷股份(002192.SZ)與億緯鋰能(300014.SZ)等一批上市公司的基礎上,繼續開展第二輪走訪上市公司工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.